Clozapine augmented with amisulpride in 3 cases of treatment-resistant early- and very early-onset schizophrenia. 2013

Ali Evren Tufan, and Irem Yalug

UI MeSH Term Description Entries
D008297 Male Males
D003024 Clozapine A tricylic dibenzodiazepine, classified as an atypical antipsychotic agent. It binds several types of central nervous system receptors, and displays a unique pharmacological profile. Clozapine is a serotonin antagonist, with strong binding to 5-HT 2A/2C receptor subtype. It also displays strong affinity to several dopaminergic receptors, but shows only weak antagonism at the dopamine D2 receptor, a receptor commonly thought to modulate neuroleptic activity. Agranulocytosis is a major adverse effect associated with administration of this agent. Clozaril,Leponex
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077582 Amisulpride A benzamide derivative that is used as an antipsychotic agent for the treatment of schizophrenia. It is also used as an antidepressive agent. 4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-methoxybenzamide,Barnetil,DAN 2163,DAN-2163,LIN 1418,LIN-1418,N-(Ethyl-1-pyrrolidinyl- 2-methyl)methoxy-2-ethylsulfonyl-5-benzamide,Solian,Sultopride,Sultopride Hydrochloride
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D012561 Schizophrenia, Childhood An obsolete concept, historically used for childhood mental disorders thought to be a form of schizophrenia. It was in earlier versions of DSM but is now included within the broad concept of PERVASIVE DEVELOPMENT DISORDERS. Childhood Schizophrenia,Childhood-Onset Schizophrenia,Childhood Onset Schizophrenia,Schizophrenia, Childhood-Onset
D012565 Schizophrenic Psychology Study of mental processes and behavior of schizophrenics. Psychology, Schizophrenic

Related Publications

Ali Evren Tufan, and Irem Yalug
January 1994, Journal of the American Academy of Child and Adolescent Psychiatry,
Ali Evren Tufan, and Irem Yalug
March 2004, Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists,
Ali Evren Tufan, and Irem Yalug
May 2010, Clinical neuropharmacology,
Ali Evren Tufan, and Irem Yalug
March 2017, Journal of child and adolescent psychopharmacology,
Ali Evren Tufan, and Irem Yalug
May 2024, Journal of clinical psychopharmacology,
Ali Evren Tufan, and Irem Yalug
January 2022, The Canadian journal of hospital pharmacy,
Ali Evren Tufan, and Irem Yalug
May 2009, International journal of geriatric psychiatry,
Ali Evren Tufan, and Irem Yalug
January 2022, The Canadian journal of hospital pharmacy,
Ali Evren Tufan, and Irem Yalug
January 1997, International journal of psychiatry in clinical practice,
Ali Evren Tufan, and Irem Yalug
May 2004, The American journal of psychiatry,
Copied contents to your clipboard!